Literature DB >> 1365624

Preliminary evidence for methamphetamine-induced behavioral and ocular effects in rat offspring following exposure during early organogenesis.

K D Acuff-Smith1, M George, S A Lorens, C V Vorhees.   

Abstract

Gravid Sprague-Dawley CD (VAF) rats received 50 mg/kg (d,l)-methamphetamine (MA) HCl (expressed as free base, N = 15) or distilled water (N = 6) by SC injection x 2/day in a 3 ml/kg volume on embryonic (E) days 7-12. Control rats were pair-fed to MA-exposed dams on days E7-18. No control dams failed to deliver; however, of 15 MA-exposed dams 4 did not deliver (2 died and 2 had completely resorbed litters). One additional MA litter had all the offspring die shortly after birth. There was no difference between groups on offspring postnatal (P) body weight. The offspring exposed prenatally to MA had significantly lower olfactory orientation scores (P9, 11, 13) to their home cage scent. In a test of early activity (P10, 12, 14) the MA-exposed progeny were marginally less active than controls. MA-exposed offspring exhibited hyperreactivity and marginally shortened response latency on a test of acoustic startle (P27). Motor activity showed no differential response in MA treated or control offspring to MA (P63) or fluoxetine challenge (P70). However, the MA offspring were more active than controls with respect to central and side activity during the second week of testing. No group differences were found for performance in a straight swimming channel or on the number of errors committed or latency to escape in a complex (Cincinnati) water maze (P84). Prenatal exposure to MA also induced eye defects (i.e., anophthalmia, microphthalmia and folded retina) in 16.7% of the progeny. However, MA did not effect hippocampal or neostriatal monoamine levels when measured on P28.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1365624     DOI: 10.1007/bf02245871

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  56 in total

1.  Open-field and Lashley III maze behaviour of the offspring of amphetamine-treated rats.

Authors:  A G Nasello; O A Ramirez
Journal:  Psychopharmacology (Berl)       Date:  1978-07-06       Impact factor: 4.530

Review 2.  Methamphetamine and related drugs: toxicity and resulting behavioral changes in response to pharmacological probes.

Authors:  L S Seiden; M S Kleven
Journal:  NIDA Res Monogr       Date:  1989

3.  Effects of transplacental exposure to cocaine and methamphetamine on the neonate.

Authors:  S D Dixon
Journal:  West J Med       Date:  1989-04

4.  Teratology in the Macaca mulatta.

Authors:  K D Courtney; D A Valerio
Journal:  Teratology       Date:  1968-05

5.  Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine.

Authors:  L S Seiden; G Vosmer
Journal:  Pharmacol Biochem Behav       Date:  1984-07       Impact factor: 3.533

6.  Effects of prenatal amphetamine exposure on the development of behavior in rats.

Authors:  H Monder
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  Decreased sensitivity of rat pups to long-lasting dopamine and serotonin depletions produced by methylamphetamine.

Authors:  J B Lucot; G C Wagner; C R Schuster; L S Seiden
Journal:  Brain Res       Date:  1982-09-09       Impact factor: 3.252

8.  Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates.

Authors:  A S Oro; S D Dixon
Journal:  J Pediatr       Date:  1987-10       Impact factor: 4.406

9.  Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers.

Authors:  G A Ricaurte; L S Seiden; C R Schuster
Journal:  Brain Res       Date:  1984-06-15       Impact factor: 3.252

10.  Behavioral and neurochemical changes in pups prenatally exposed to methamphetamine.

Authors:  M Sato; Y Fujiwara
Journal:  Brain Dev       Date:  1986       Impact factor: 1.961

View more
  14 in total

1.  Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study.

Authors:  Amelia M Arria; Chris Derauf; Linda L Lagasse; Penny Grant; Rizwan Shah; Lynne Smith; William Haning; Marilyn Huestis; Arthur Strauss; Sheri Della Grotta; Jing Liu; Barry Lester
Journal:  Matern Child Health J       Date:  2006-01-05

Review 2.  Fetal effects of psychoactive drugs.

Authors:  Amy L Salisbury; Kathryn L Ponder; James F Padbury; Barry M Lester
Journal:  Clin Perinatol       Date:  2009-09       Impact factor: 3.430

3.  Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand.

Authors:  Linda L LaGasse; Trecia Wouldes; Elana Newman; Lynne M Smith; Rizwan Z Shah; Chris Derauf; Marilyn A Huestis; Amelia M Arria; Sheri Della Grotta; Tara Wilcox; Barry M Lester
Journal:  Neurotoxicol Teratol       Date:  2010-07-06       Impact factor: 3.763

4.  Methamphetamine detection in maternal and neonatal hair: implications for fetal safety.

Authors:  F Garcia-Bournissen; B Rokach; T Karaskov; G Koren
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-10-31       Impact factor: 5.747

Review 5.  Developmental and behavioral consequences of prenatal methamphetamine exposure: A review of the Infant Development, Environment, and Lifestyle (IDEAL) study.

Authors:  Lynne M Smith; Sabrina Diaz; Linda L LaGasse; Trecia Wouldes; Chris Derauf; Elana Newman; Amelia Arria; Marilyn A Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Lynne M Dansereau; Charles Neal; Barry M Lester
Journal:  Neurotoxicol Teratol       Date:  2015-07-23       Impact factor: 3.763

Review 6.  Ocular manifestations of crystal methamphetamine use.

Authors:  Ribhi Hazin; Jean Lud Cadet; Malik Y Kahook; Dunia Saed
Journal:  Neurotox Res       Date:  2009-02-28       Impact factor: 3.911

7.  Methamphetamine induces long-term alterations in reactivity to environmental stimuli: correlation with dopaminergic and serotonergic toxicity.

Authors:  Marco Bortolato; Roberto Frau; A Paola Piras; William Luesu; Valentina Bini; Giacomo Diaz; Gianluigi Gessa; M Grazia Ennas; M Paola Castelli
Journal:  Neurotox Res       Date:  2009-02-25       Impact factor: 3.911

8.  Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning.

Authors:  Tracy M Reed; David R Repaske; Gretchen L Snyder; Paul Greengard; Charles V Vorhees
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

9.  Methamphetamine exposure during early postnatal development in rats: II. Hypoactivity and altered responses to pharmacological challenge.

Authors:  C V Vorhees; K G Ahrens; K D Acuff-Smith; M A Schilling; J E Fisher
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

10.  Vulnerability to (+)-methamphetamine effects and the relationship to drug disposition in pregnant rats during chronic infusion.

Authors:  Sarah J White; Elizabeth M Laurenzana; William Brooks Gentry; Howard P Hendrickson; David Keith Williams; Keith W Ward; Samuel Michael Owens
Journal:  Toxicol Sci       Date:  2009-06-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.